MARRA, ALBERTO MARIA
 Distribuzione geografica
Continente #
NA - Nord America 1.986
EU - Europa 1.016
AS - Asia 692
AF - Africa 54
SA - Sud America 12
Totale 3.760
Nazione #
US - Stati Uniti d'America 1.961
IT - Italia 530
SG - Singapore 457
CN - Cina 175
NL - Olanda 137
UA - Ucraina 129
DE - Germania 55
CI - Costa d'Avorio 54
IN - India 35
IE - Irlanda 34
FI - Finlandia 33
FR - Francia 26
CA - Canada 25
ES - Italia 19
VN - Vietnam 12
CZ - Repubblica Ceca 9
GB - Regno Unito 9
SE - Svezia 9
BG - Bulgaria 7
AR - Argentina 5
HK - Hong Kong 5
CO - Colombia 4
RS - Serbia 4
AT - Austria 3
RO - Romania 3
EC - Ecuador 2
GR - Grecia 2
JP - Giappone 2
MY - Malesia 2
SI - Slovenia 2
TR - Turchia 2
CH - Svizzera 1
CL - Cile 1
EE - Estonia 1
HU - Ungheria 1
IR - Iran 1
LU - Lussemburgo 1
PL - Polonia 1
TJ - Tagikistan 1
Totale 3.760
Città #
Singapore 381
Chandler 325
Ashburn 179
Millbury 163
Naples 147
Amsterdam 131
Santa Clara 105
Des Moines 81
Lawrence 81
Napoli 55
Beijing 50
Nanjing 47
Princeton 40
Boston 36
Pune 25
Wilmington 22
Castellón 18
Rome 16
Ottawa 15
Washington 15
Salerno 14
Seattle 14
Milan 13
Dong Ket 12
Dallas 11
Houston 11
Pomigliano d'Arco 11
Dearborn 10
Gragnano 9
Guangzhou 9
Jiaxing 9
Dublin 8
Kronberg 8
Munich 8
Olomouc 8
Bari 7
Changsha 7
Fairfield 7
Los Angeles 7
Woodbridge 7
Hebei 6
Nanchang 6
Norwalk 6
Torre del Greco 6
Jacksonville 5
Lappeenranta 5
Marigliano 5
Shenyang 5
Tianjin 5
Toronto 5
Andover 4
Ann Arbor 4
Beograd 4
Bogotá 4
Calvizzano 4
Delhi 4
Helsinki 4
Modica 4
Nola 4
Redwood City 4
Richmond 4
San Mateo 4
Augusta 3
Cambridge 3
Casalnuovo di Napoli 3
Caserta 3
Covington 3
Formia 3
Magenta 3
Marsala 3
New Delhi 3
Perugia 3
Acerra 2
Acqui Terme 2
Assoro 2
Avellino 2
Babahoyo 2
Boardman 2
Bologna 2
Cardito 2
Casagiove 2
Castel Volturno 2
Castellammare di Stabia 2
Cellole 2
Changchun 2
Comiziano 2
Düsseldorf 2
Genzano di Roma 2
Hong Kong 2
Kuala Lumpur 2
Marano di Napoli 2
Padova 2
Portland 2
Providence 2
Pugliano 2
San Donato Milanese 2
San Nicola la Strada 2
San Vendemiano 2
Sandusky 2
Seacroft 2
Totale 2.310
Nome #
Carotid plaque detection improves the predictive value of CHA(2)DS(2)-VASc score in patients with non-valvular atrial fibrillation: The ARAPACIS Study 84
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 78
Growth hormone deficiency is associated with worse cardiac function, physical performance, and outcome in chronic heart failure: Insights from the T.O.S.CA. GHD study 73
Defining aging phenotypes and related outcomes: Clues to recognize frailty in hospitalized older patients 71
The Tosca Registry: An Ongoing, Observational, Multicenter Registry for Chronic Heart Failure 66
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 64
Klinefelter syndrome, cardiovascular system, and thromboembolic disease: Review of literature and clinical perspectives 63
Multiple hormone deficiency syndrome in heart failure with preserved ejection fraction 62
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 61
Growth hormone deficiency in patients with chronic heart failure and beneficial effects of its correction 57
Bowel Angiodysplasia and Myocardial Infarction secondary to an ischaemic imbalance: A case report 54
Multiple hormonal and metabolic deficiency syndrome in chronic heart failure: rationale, design, and demographic characteristics of the T.O.S.CA. Registry 52
Human heart shifts from IGF-1 production to utilization with chronic heart failure 50
Detectable interleukin-9 plasma levels are associated with impaired cardiopulmonary functional capacity and all-cause mortality in patients with chronic heart failure 50
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 49
The T.O.S.CA. Project: research, education and care. 47
Growth Hormone as Biomarker in Heart Failure 47
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 47
The Right Heart International Network (RIGHT-NET): Rationale, Objectives, Methodology, and Clinical Implications 46
Cardiovascular abnormalities and impaired exercise performance in adolescents with congenital adrenal hyperplasia 43
Right Ventricular Functional Reserve in Early-Stage Idiopathic Pulmonary Fibrosis: An Exercise Two-Dimensional Speckle Tracking Doppler Echocardiography Study 43
IGF-1 predicts survival in chronic heart failure. Insights from the T.O.S.CA. (Trattamento Ormonale Nello Scompenso CArdiaco) registry 42
Biomarkers in Pulmonary Hypertension 40
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 40
Correction to: Human heart shifts from IGF-1 production to utilization with chronic heart failure (Endocrine, (2019), 65, 3, (714-716), 10.1007/s12020-019-01993-y) 39
Anti remodeling therapy: New strategies and future perspective in post-ischemic heart failure. Part II 39
Cardiovascular abnormalities in Klinefelter Syndrome 38
Pregabalin-induced first degree atrioventricular block in a young patient treated for pain from extrapulmonary tuberculosis 37
Growth Hormone Therapy in Heart Failure 37
Multiple hormonal and metabolic deficiency syndrome predicts outcome in heart failure: the T.O.S.CA. Registry 37
SOCS1 gene transfer accelerates the transition to heart failure through the inhibition of the gp130/JAK/STAT pathway. 36
Gender-related differences in pulmonary arterial hypertension targeted drugs administration 36
Pattern of in-hospital changes in drug use in the older people from 2010 to 2016 36
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 36
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 36
Change of right heart size and function by long-term therapy with riociguat in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension 35
Reference ranges for and determinants of right ventricular area in healthy adults by two-dimensional echocardiography 35
Bleeding management in patients on new oral anticoagulants 35
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 35
Circulating cell-free DNA levels are associated with adverse outcomes in heart failure: testing liquid biopsy in heart failure 35
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 35
Effetti della terapia sostitutiva con GH sui parametri funzionali e di struttura cardiovascolare in pazienti con scompenso cardiaco e deficit di GH 34
Heart failure with preserved ejection fraction: Squaring the circle between comorbidities and cardiovascular abnormalities 34
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 33
Right Heart Pulmonary Circulation Unit Involvement in Left-Sided Heart Failure: Diagnostic, Prognostic, and Therapeutic Implications 33
Anabolic hormones and heart failure with preserved ejection fraction: looking for Ariadne's thread 33
Right Heart Pulmonary Circulation Unit Response to Exercise in Patients with Controlled Systemic Arterial Hypertension: Insights from the RIGHT Heart International NETwork (RIGHT-NET) 33
Klinefelter syndrome, insulin resistance, metabolic syndrome, and diabetes: review of literature and clinical perspectives 32
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 32
Prospettive di intervento della riabilitazione cardiologica sulla qualità della vita nei pazienti con scompenso cardiaco cronico e deficit di GH. 31
Reference ranges and determinants of right ventricle outflow tract acceleration time in healthy adults by two-dimensional echocardiography 31
Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study 31
Anti remodeling therapy: New strategies and future perspective in post-ischemic heart failure: Part I 31
Combined effects of growth hormone and testosterone replacement treatment in heart failure 31
Correction to: Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study (Internal and Emergency Medicine, (2018), 13, 5, (651-660), 10.1007/s11739-018-1835-9) 30
Postoperative myocardial injury: Trying to square the circle 30
Acute Heart Failure: Diagnostic-Therapeutic Pathways and Preventive Strategies-A Real-World Clinician's Guide 29
Testosterone treatment in chronic heart failure. Review of literature and future perspectives 29
A multicentric quality-control study of exercise Doppler echocardiography of the right heart and the pulmonary circulation. The RIGHT Heart International NETwork (RIGHT-NET) 29
Age-changes in right ventricular function–pulmonary circulation coupling: from pediatric to adult stage in 1899 healthy subjects. The RIGHT Heart International NETwork (RIGHT-NET) 29
Anabolic/catabolic imbalance in chronic heart failure 28
Biomarkers and Imaging: Complementary or Subtractive? 28
Growth hormone replacement delays the progression of chronic heart failure combined with growth hormone deficiency: an extension of a randomized controlled single-blind study. 27
Clinical features and management of venous thromboembolism in patients with Behçet’s syndrome: a single-center case–control study 27
Progressive right ventricular dysfunction and exercise impairment in patients with heart failure and diabetes mellitus: insights from the T.O.S.CA. Registry 26
The impairment of the Growth Hormone/Insulin-like growth factor 1 (IGF-1) axis in heart failure: A possible target for future therapy 26
Physiologic correlates of tricuspid annular plane systolic excursion in 1168 healthy subjects 26
Clinical trials in pulmonary arterial hypertension: a glimpse of history 26
How to Treat Right Heart Failure. Tips for Clinicians in Everyday Practice 25
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 25
ERS statement on exercise training and rehabilitation in patients with severe chronic pulmonary hypertension 25
When Pulmonary Hypertension Complicates Heart Failure 25
Right ventricular-arterial uncoupling independently predicts survival in COVID-19 ARDS 25
Can pulse wave velocity (PWV) alone express arterial stiffness? A neglected tool for vascular function assessment 25
An unusual case of dilated cardiomyopaty associated with partial hypopituitarism. 24
Feasibility of semi-recumbent bicycle exercise Doppler echocardiography for the evaluation of the right heart and pulmonary circulation unit in different clinical conditions: the RIGHT heart international NETwork (RIGHT-NET) 24
Role of Cardiac Magnetic Resonance Imaging in Heart Failure 23
Vein wall thickness and severity of pulmonary involvement due to sars n-cov2 virus infection 22
Imaging the right heart pulmonary circulation unit: Insights from advanced ultrasound techniques 22
Letter to the Editor: "Cardiometabolic biomarkers and their temporal patterns predict poor outcome in chronic heart failure (Bio-SHiFT study)" 22
Idiopathic pulmonary fibrosis telemedicine management during COVID-19 outbreak 22
Exploring the Cardiotoxicity Spectrum of Anti-Cancer Treatments: Definition, Classification, and Diagnostic Pathways 21
Pulmonary arterial hypertension-related myopathy: An overview of current data and future perspectives 21
Heart failure management during the COVID-19 outbreak in Italy: a telemedicine experience from a heart failure university tertiary referral centre 21
Incidence of pulmonary hypertension and determining factors in patients with systemic sclerosis 20
Guidelines on the management of atrial fibrillation in the emergency department: a critical appraisal 20
Frequency of Left Ventricular Hypertrophy in Non-Valvular Atrial Fibrillation 20
Glucose Metabolism Abnormalities in Heart Failure Patients: Insights and Prognostic Relevance. 20
Mildly Elevated Pulmonary Hypertension: Gray Zone or Already a Disease? 19
What have we learned so far from the sex/gender issue in heart failure? An overview of current evidence 19
A focused review of gender differences in antithrombotic therapy 19
The impact of gender in cardiovascular medicine: Lessons from the gender/sex-issue in heart failure 19
Bowel Angiodysplasia and Myocardial Infarction secondary to an ischaemic imbalance: a case report 18
Advanced imaging in pulmonary hypertension: emerging techniques and applications 18
Metabolic Syndrome in Heart Failure: Friend or Foe? 17
Haemodynamic phenotypes and survival in patients with systemic sclerosis: The impact of the new definition of pulmonary arterial hypertension 17
Rationale and protocol of a double-blind, randomized, placebo-controlled trial to test the efficacy, safety, and tolerability of dimethyl fumarate in Friedreich Ataxia (DMF-FA-201) 16
Insulin-like growth factor-1 (IGF-1) as predictor of cardiovascular mortality in heart failure patients: data from the T.O.S.CA. registry 16
Early treatment with ambrisentan of mildly elevated mean pulmonary arterial pressure associated with systemic sclerosis: a randomized, controlled, double-blind, parallel group study (EDITA study) 15
Assessment of pulmonary vascular response to exercise with Doppler-echocardiography: State of the art? 15
Totale 3.415
Categoria #
all - tutte 23.296
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.296


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202099 0 0 0 0 10 14 3 3 10 28 26 5
2020/2021350 126 18 19 20 21 22 18 17 30 16 14 29
2021/2022687 10 7 19 6 8 7 23 19 58 77 159 294
2022/2023959 122 53 32 21 110 88 75 82 146 143 64 23
2023/2024930 33 118 131 90 47 118 15 117 18 31 129 83
2024/2025693 241 259 32 71 90 0 0 0 0 0 0 0
Totale 4.095